Michael Severino, AbbVie president and soon-to-be Flagship Pioneering CEO-partner

Ab­b­Vie pres­i­dent Michael Sev­eri­no heads to Flag­ship as biotech in­cu­ba­tor's third CEO-part­ner in six days

Ab­b­Vie pres­i­dent and vice chair Michael Sev­eri­no is leav­ing the Chica­go-area phar­ma gi­ant on May 31 to be­come a CEO-part­ner at pro­lif­ic biotech cre­ator Flag­ship Pi­o­neer­ing in June. He’s the third CEO-part­ner to be named at the in­cu­ba­tor, which is be­hind the likes of Mod­er­na, in the past six days.

He no­ti­fied the Hu­mi­ra drug­mak­er on April 8 of his new ca­reer am­bi­tions, ac­cord­ing to an Ab­b­Vie SEC fil­ing Wednes­day morn­ing. He’s de­part­ing af­ter three and a half years in the pres­i­dent and vice chair posts. Pri­or to that, he spent near­ly five years as CSO.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.